NCT00398931View on ClinicalTrials.gov

FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,099

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

MK0217, alendronate sodium / Duration of Treatment : 5 Years

DRUG

Comparator : placebo (unspecified) /Duration of Treatment : 5 Years

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00398931 - FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051) | Biotech Hunter | Biotech Hunter